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Currently, experimental animals are widely used in biological and medical research.
However, the scientific community has raised several bioethical concerns, such as the
number of animals required to achieve reproducible and statistically relevant results.
These concerns involve aspects related to pain, discomfort, and unwanted animal loss.
Retrospectively, we compare two different approaches for anesthesia dosage: a mobile
app for dose calculation and a standard dose calculation. A total of 939 C57BL/6J and
Swiss mice were analyzed. We collected data on intraoperative and anesthesia-related
mortality as described in electronic or physical handwritten records. Our results showed
that the mobile app approach significantly reduces anesthetic-related deaths upon using
doses of ketamine and xylazine. The results suggest that anesthesia-related mortality
can be minimized even more using information technology approaches, helping to solve
an old but transversal challenge for researchers working with experimental mice. The
mobile app is a free and open code which could be implemented worldwide as an
essential requirement for all anesthetic procedures in mice using xylazine and ketamine
combination. As an open code app, the Labinsane initiative could also represent the
starting point to unify and validate other anesthetic procedures in different species
and strains.
Keywords: xylazine, anesthesia, mortality and morbidity, smartphone, mobile app

INTRODUCTION
Annually, millions of animals are used for experimental purposes (1–3). Experimental mice
are usually anesthetized intraperitoneally with a ketamine and xylazine solution (4–7). An
intraperitoneal procedure permits rapid application and fast anesthetic effect. However, the reasons
why mice die during the anesthetic procedure could be attributed to the inappropriate ketamine
and xylazine dosage, the lack of supplemental oxygen, and attention to details such as body
temperature, stress associated with handling, and incorrect intraperitoneal technique. Moreover,
previous intraperitoneal ketamine and xylazine combinations have caused several challenges
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related to a low margin of safety, prolonged recovery, and
persistence of lost reflexes in mice (5, 8, 9). The ketamine and
xylazine doses range from 60 to 200 mg kg−1 of ketamine and
4 to 26.4 mg kg−1 of xylazine (4, 5, 8–11). However, serious
inconsistent rates of anesthesia-related mortality (0–100%) have
been reported (5, 8–11).
Recent studies have shown that the MIT App Inventor, a
free and open-source software, can improve the performance
and quality of the data analyzed, helping operators to make
well-informed decisions (12). A previous report validated a
smartphone app for the calculation of CO2 in inhalational
anesthesia (13), supporting the concept that a mobile app could
help operators to calculate individual anesthetic doses. Here, our
objective was to develop a mobile app to improve the accuracy
of intraperitoneal anesthetic doses for mice. In this way, we
used a range of previously tested safe doses (5, 11), herein
ketamine (mg kg−1 ), and xylazine (mg kg−1 ), in the following
proportions: 70/7, 80/8, and 100/10, which are now contained in
the “Labinsane” mobile app. Then, we compared the Labinsane
anesthetic protocol to the protocol of 133 mg kg−1 ketamine with
27 mg kg−1 xylazine.

monitoring of the temperature of the animal. Furthermore, only
male mice were included.
The anesthetic injections are a routine procedure in our lab.
Records with the following pattern were selected: using only
a mixture of xylazine (Anasedan, Brazil), ketamine (Dopalen,
Brazil), with or without diazepam, and saline (0.9%) solution.
Intraperitoneal injections were performed in mice in the dorsal
recumbent position. The anesthetic combination was made up as
a single injection.

Criteria for Exclusion
All incomplete records were excluded from the analysis:
anesthesia-related mortality, lost breath, or rigor mortis
occurring after 2 h after induction of anesthesia, mice fed with
a high-fat diet, or animals treated with different specific care
support before, during, or after the anesthetic procedure such as
oxygen supplementation.

Anesthetic Procedure Screened
For both the standard dose and individual dose, the animals
were weighed on the same day of the anesthetic procedure.
The anesthetic combination was freshly prepared for each
experiment, as previously described (10). The final solution was
used immediately. Standard doses were prepared as previously
described (6), with some local adaptations. Briefly, the final
solution of the standard dose was prepared with 400 µl xylazine
(2 g/100 ml), 400 µl ketamine (10 g/100 ml), and 200 µl saline
solution. The standard dose combination (80–100 µl of the
mixture, according to weight) was administered intraperitoneally
once by procedure. The final solution of the individual dose
was prepared and calculated by the Labinsane mobile app.
Briefly, the mobile app processes body weight, calculates a master
anesthetic combination, and then indicates the individual volume
(in µl) to administer for each individual mouse (Figure 2). A
specific individual dose adjusted to the body weight of the mouse
was administered intraperitoneally once by procedure. For the
C57BL/6 strain, a range of previously tested safe doses was used.
Herein, ketamine (mg kg−1 ) and xylazine (mg kg−1 ) were in the
following proportions: 70/7, 80/8, and 100/10 (3, 7), while for the
Swiss strain, we added diazepam (5 mg kg−1 ) (12).

MATERIALS AND METHODS
Retrospectively, anesthetic procedure records from C57BL/6J
and Swiss mice were included. We collected electronic and
physical handwritten records written between 2015 and 2021
from eight researchers (Figure 1). The records included from
different projects were approved by the ethical committee of
the University Campinas (#4330-1A, #5521-1, #5425-1, #53491, #4637-1, #4072-1, #3826-1, #5414-1, #4930-1 and #4699-1).
Records of anesthetic procedures were conducted according to
the “Guide for the Care and Use of Laboratory Animals” (14). The
mice were maintained under specific pathogen-free conditions in
individual cages in a regimen of 12-h dark and 12-h light cycles
and room temperature of 21◦ C. All mice had ad libitum access to
food (3.7 kcal g−1 ) and water.

Criteria for Inclusion
Anesthetic records from intraoperative mortality were collected.
Anesthesia-related mortality was defined as lost breath or rigor
mortis up to 2 h after the induction of anesthesia. The anesthetic
procedure characteristics were as follows: intraperitoneal route,
using an insulin syringe, 31G needle, sterile saline solution or
distilled water for injections, 10 g/100 ml stock ketamine and
2 g/100 ml stock xylazine (C57BL/6J), or 10 g/100 ml stock
ketamine, 2 g/100 ml stock xylazine, and 0.5 g/100 ml stock
diazepam (Swiss). The animals were on a chow diet, and
individual weights were measured on the same day of the
anesthetic procedures. We collected records from animals of two
procedures: two symmetrical full-thickness excisional wounds
(6-mm biopsy punch) created on the back of each mouse as
described previously (15) and stereotaxic surgery carried out
using a stereotaxic frame (16). All surgeries were conducted up
to 1 h after anesthesia induction. Immediately after surgery, the
mice were placed on a new germ-free surface in a temperaturecontrolled room (25◦ C), without oxygen supplementation or
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Statistical Analyses
Data extracted from the original records were pooled on a
Microsoft Excel spreadsheet (Microsoft Corporation, 2007). All
statistical tests were performed in GraphPad Prism (6.0v). Data
were analyzed with Fisher’s exact test (two-sided) and odds
ratios. Statistical significance was set as alpha <0.05 and 95%
confidence interval (CI). For the linear model, we used a modified
Poisson regression model, with robust variance (17). The model
was adjusted considering death as the dependent variable. The
variables “app used”, “strain,” and “age” were also considered as
independent variables. In the results, the estimates obtained from
the prevalence ratio were presented as well as their respective
confidence intervals and p-values.
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FIGURE 1 | Anesthetic records from C57BL/6J and Swiss mice Collected records from Standard or Mobile app approach of anesthesia-related mortality. Records
were collected between 2015 and 2021.

FIGURE 2 | Labinsane schematic workflow. Individual animal weights were processed by the Labinsane mobile app. A master anesthetic cocktail was calculated
based on the total number of animals and weights. The Mobile app approach showed an adjusted-to-weight anesthetic dose for each animal.

Labinsane Formula

stock volume.
A =(

x = A+B+C

weigh

y = A+B +C+D

×

KP
× KC)
1, 000

“A” from the Labinsane formula is the sum of all body
weights of mice times ketamine prescription times ketamine
stock concentration.
X
XP
×
× XC)
B =(
1, 000

The x formula describes the final master anesthetic solution for
the C57BL/6 mice. The y formula describes the final master
anesthetic solution for the Swiss mice. In both formulas, A
represents the final ketamine stock volume, B the final xylazine
stock volume, C the final saline volume, and D the final diazepam
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“B” from the Labinsane formula is the sum of all body
weights of mice times xylazine prescription times xylazine
stock concentration.
X
DP
×
D =(
× DC)
1, 000

TABLE 1 | Characteristics of mice.
Number of animals
Average age (weeks ± SD)

C57BL/6J (754)

weigh

Sex (%)

“D” from the Labinsane formula is the sum of all body
weights of mice times diazepam prescription times diazepam
stock concentration.

Strain (%)
Average weight (g)

C = (A + B) × 4
C = (A + B + D) × 3

Surgical procedure (%)

“C” from the Labinsane formula is the sum of the final ketamine
stock volume and final xylazine stock volume times the dilution
factor. The dilution factor here is a constant: “4” for C57BL/6
mice and “3” for Swiss mice.
The records collected described three different dose
prescriptions of ketamine (mg kg−1 ) and xylazine (mg kg−1 )
in the following proportions: 70/7, 80/8, and 100/10, with the
same prescription for diazepam (5 mg kg−1 ). The anesthetic
dose prescription was defined according to the need for long or
short procedures. For the standard protocol, we collected records
describing 133 mg kg−1 ketamine and 27 mg kg−1 xylazine of
dose prescription.

Individual

8.0 (0)

8.0 (0)

7.6 (0.5)

8.0 (0)

Females (0)

0

0

Males (939)

100

100

Swiss (185)

49

51

C57BL/6J (754)

16

84

Swiss (185)

33.8

33.5

C57BL/6J (754)

25.2

25.1

Stereotaxic surgery (387)

32.2

67.8

Full-thickness biopsy (552)

17.2

82.8

Age, sex, strain, weight, and procedure profile of mice with total number, separated by
standard or individual protocol. Values expressed in weeks with standard deviation (weeks
± SD), percentage (%), and grams (g).

TABLE 2 | Multivariables.
Variable

Death

p-Value

No
n

Yes
%

n

%
<0.0001a

App used

RESULTS
Labinsane Mobile App Decreased
Anesthesia-Related Mortality

No

149

89.76

17

10.24

Yes

765

98.97

8

1.03

C57

733

97.21

21

2.79

Swiss

181

97.84

4

2.16

70–100

765

98.97

8

1.03

133

149

89.76

17

10.24

7

61

93.85

4

6.15

8

853

97.60

21

2.40

0.8014a

Strain

Over the 6 years of the study, 939 anesthetized mice were
evaluated: 754 C57BL/6 and 185 Swiss mice (Table 1). This
study identified 25 intraoperative and anesthesia-related deaths
within all anesthetic procedures. The individual protocol showed
an anesthesia-related mortality rate of 1.03%. On the other
hand, mice anesthetized using the standard protocol showed
an anesthesia-related mortality rate of 10.24% (Table 2). The
association between the mobile app and survival outcome was
statistically significant (Table 2). Moreover, the mobile app
approach suggests a protective effect (Table 3), with a prevalence
ration of 0.06-fold the anesthesia-related deaths compared to the
standard dose procedure (odds ratio, 0.06; 95% CI, 0.02–0.13; p
< 0.0001). We excluded 123 electronic records of mice fed with
a high-fat diet or of animals that received different specific care
support such as oxygen supplementation.
Different doses of ketamine/xylazine for the mobile app
protocol (70/7, 80/8, and 100/10 mg/mg per kg) or standard
protocol (133/27 mg/mg per kg) were evaluated. Identified
as the higher anesthesia-related mortality dose was 133 mg of
ketamine/27 mg of xylazine per kilogram when compared to the
other weight-adjusted doses (Table 2).
Next, it was evaluated whether different strains, C57BL/6 or
Swiss, age, or surgical procedure could influence the anesthesiarelated mortality rate. No significant difference in anesthesiarelated mortality was identified between C57BL/6 and Swiss mice,
7- and 8-week-old, or between full-thickness excisional biopsy
and stereotaxic surgery (Tables 2, 3).
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Swiss (185)

Standard

<0.0001a

Concentration

0.0880a

Age, weeks

0.5840b

Procedure
Full-thickness excisional biopsy

535

97.10

16

2.90

Stereotaxic surgery

379

97.68

9

2.32

Descriptions of the variables app used, strain, drug concentration, age, and procedure
were presented.
a Fisher’s exact test.
b Chi-square test.

Labinsane Mobile App Matched All
Anesthetic Dose Calculations
To validate the mobile app anesthetic dose calculation, the
Labinsane app was challenged to reproduce the results of the
individual doses calculated by a Microsoft Excel formula. The
Microsoft Excel formula was chosen because it is one of the
top stable software available. Randomly, 449 mice were tested,
showing that the Labinsane mobile app matched all (100%) the
individual anesthetic doses calculated by the Microsoft Excel
formula (Table 4) with no statistical difference (p = 0.9). These
results suggested no errors in the Labinsane mobile app code.
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TABLE 3 | Poisson regression.
Dependent variable

Prevalence ratioa

Independent variables

95% CI
Lower

Deatha

a The

p-value
Upper

App used (ref = no)

0.06

0.02

0.13

Strain (ref = Swiss)

2.13

0.39

11.55

0.3797

Age, weeks (ref = 7)

2.03

0.31

13.18

0.4585

Procedure (ref = wound)

0.54

0.11

2.61

0.4436

<0.0001

probability of presenting the result “yes” was estimated; n = 939.

devices in the workplace. Mobile phones were easily disinfected
and speeded up master anesthetic calculations as well as the
individual anesthetic dose calculation.
Several advantages of volatile anesthetics over injectables
have been shown. However, anesthetic procedures using airways
require specific equipment, which can interfere with the
experiment result and increases both cost and workspace usage.
If volatile anesthetics cannot be applied, injectable anesthesia
is indicated (18). Intraperitoneal anesthetic protocols based on
the injection of ketamine–xylazine solution are widely used
in experiments with rodents due to the low cost, minimum
training, and the fact that no equipment is being required (4).
Nevertheless, there is a wide variation in the recommended
dose, which is possibly due to differences between mouse
strains, type, and duration of the procedure, health conditions,
age, and research goals (4, 8, 10, 19). Previous reports
compared the efficacy of the intraperitoneal and subcutaneous
administration of ketamine (100 mg/ml) and xylazine (20 mg/ml)
solution for inducing surgical anesthesia. Among C57BL/6,
BALB, and ICR mice, no death occurred in the subcutaneous
administration groups, while 16.7% (10 of 60 mice) of mice
injected intraperitoneally died (10). Specifically, more females
died after the intraperitoneal injection compared with males (10).
Previous reports have also shown that the ketamine, xylazine,
and diazepam combination is effective to induce anesthesia for
surgical procedures (20–24).
The principal causes of unsafe medication in humans are
related to failures in drug preparation and lack of treatment
standardization (25). Experimental animal safety should also
ensure the proper anesthetic dose calculation and administration.
In this way, the Labinsane mobile app seeks to ensure the
safety of C57BL/6 and Swiss mice by pursuing proper individual
anesthetic dose calculation and administration.
We decided to use “4” and “3” as dilution factors in the
mobile app formulas, with the aim to increase the total volume
to administer. By increasing the dilution factor, we decreased
the anesthetic agent concentrations in every microliter of the
final cocktail. In this way, if any operator mistake occurs, the
volume of the anesthetic agents is low (in µl), protecting the
mice from overdoses. These dilution factors helped the operators
with anesthetic volumes that were easier to fit in common insulin
syringes (1 ml). This altogether protects the mice from human
mistakes. This approach suggests that the mobile app could
improve mice safety related to anesthetic administration. We
believe that this method could be better than just calculating the

TABLE 4 | Labinsane validation.
Excel formula
Animals
Minimum (µl)

Labinsane

449

449

114.6

114.6
130.7

Median (µl)

130.7

Maximum (µl)

249.8

250

Mean (µl)

146.1

145.9

Standard deviation (µl)

31.9

31.6

Standard error of the mean (µl)

1.5

1.5

Lower 95% confidence interval (CI; µl)

143

143

Upper 95% CI (µl)

149

148.8

Number of animals: n, 449. Median, mean, standard deviation, standard error, and
confidence interval comparing the Microsoft Excel spreadsheet and Labinsane mobile
app. Unpaired t-test: p-value, 0.9432.

DISCUSSION
The Principles of Humane Experimental Technique published in
1959 by Russell and Burch proposed that all efforts should be
made to minimize the use and suffering of experimental animals
in biological and health research (3R). Today, after 60 years, we
are still struggling to achieve the high standards idealized by
Russell and Burch.
Despite the recommended anesthetic doses being well known
worldwide, the final injected doses could be different than
those calculated. Several animals for experiments, preparation
of master anesthetic solutions, small drug volumes, and the
volumetric limitations of syringe systems could interfere in the
proper application of the recommended dose rates. We asked
whether we could improve the reported average mortality using
a ketamine and xylazine combination. First, it was tested in a
Microsoft Excel spreadsheet containing the proper prescription
formula. However, after implementation, adherence to the new
MS Excel-based dose calculation brought new difficulties for
operators—for instance, animal biosafety limitations, aseptic
concerns about personal computers in laboratories performing
animal procedures, low volumes of anesthetic to remove from
the flask, highly concentrated residual anesthetic volumes in the
syringe, and limitations of syringe systems without the capacity
to fractionate small volumes of anesthetics. To solve some of
these complexities, we tried a different approach and developed a
mobile app. Using the Labinsane mobile app on personal mobile
phones, researchers, and operators were able to use personal
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that a MIT App Inventor-based app decreased anesthesiarelated mortality and matched all anesthetic dose calculations.
The results suggest that anesthesia-related mortality can be
minimized even more using information technology approaches.
The open code of Labinsane will be available after publication
on the GitHub site (https://github.com/blinkeado/labinsane) for
future protocol validation.

drug dosages on a milligram-per-kilogram basis with standard
protocol because it is ready to use, already tested, and could be an
open initiative to automate the drug calculation process in other
species and strains.
The MIT App Inventor platform (appinventor.mit.edu) allows
researchers to easily create new mobile apps. Indeed App
Inventor apps have been shown to improve data analysis and
help in making well-informed decisions (12). The use of the App
Inventor has also contributed to children’s learning (26), home
automation (27), and self-care actions (28). Our study established
that Labinsane, a MIT-based mobile app, helps researchers to
markedly reduce anesthesia-related mortality. We encourage
researchers to validate new experimental animal strains and
species based on modular collaboration with Labinsane to
decrease anesthetic-related death.
Due to the retrospective nature of this study, we recommend
limiting the interpretation of our results to the variants
herein described as well as avoiding extrapolation to other
scenarios. The mice in the mobile app protocol received a lower
ketamine/xylazine drug concentration compared to the standard
protocol. We also collected records only from male mice, and
previous reports (10) showed that female mice mortality is
higher than male mortality. In this way, future studies will
be needed to determine the mobile app accuracy for female
anesthesia induction.
The xylazine and ketamine dose regime proposed by the
mobile app protocol is lower than the standard dose used, and
even the ratio between the dose of xylazine and ketamine between
groups is different. In fact, the mobile app protocol proposes
a reduction, especially of the xylazine dose. Similar to previous
studies, the mobile app protocol introduced a different dose
regimen in accordance with the duration of the procedure (4,
8, 10, 19). The xylazine dosage used in the standard protocol
was also 0.6 mg/kg higher than the higher dose reported in
the literature. In this way, future studies will be necessary to
determine the relationship of anesthesia-related mortality with
a similar ketamine/xylazine concentration using this mobile
app initiative.

DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.

AUTHOR CONTRIBUTIONS
CJ contributed to conceptualization, formal analysis,
methodology, investigation, writing of the original draft,
and review and editing of the manuscript. RC contributed to
the methodology, investigation, and writing of the original
draft. AZ, BA, KM, GN, TP, and VP contributed to the
investigation and writing of the original draft. BS contributed
to conceptualization and writing of the original draft. WV
contributed to review and editing of the manuscript and
formal analysis. LV contributed to formal analysis, resources,
review and editing of the manuscript, and supervision. EA
contributed to conceptualization, methodology, formal analysis,
resources, writing of the original draft, review and editing of
the manuscript, and supervision. All authors contributed to the
article and approved the submitted version.

FUNDING
This study was supported by the Coordination for
the Improvement of Higher Education Personnel
(88882.434714/2019-01 and 88881.190035/2018-01). This study
was financed in part by the Coordenação de Aperfeiçoamento de
Pessoal de Nível Superior, Brasil (CAPES), Finance Code 001.

ACKNOWLEDGMENTS

CONCLUSIONS

Many thanks go to Dr. J. Morari, G. Ferraz, and specially to
Marcio Cruz for technical assistance. Many thanks also go to
Henrique Ceretta for statistical guidance and technical assistance.

The current study was conducted to validate a mobile app for
anesthetic dose calculation. The results of the study demonstrated

REFERENCES

5. Smith W. Responses of laboratory animals to some injectable
anaesthetics. Lab Anim. (1993) 27:30–9. doi: 10.1258/0023677937810
82377
6. Schuetze S, Manig A, Ribes S, Nau R. Aged mice show an increased mortality
after anesthesia with a standard dose of ketamine/xylazine. Lab Anim Res.
(2019). 35:8. doi: 10.1186/s42826-019-0008-y
7. Gergye CH, Zhao Y, Moore RH, Lee VK, A. Comparison of ketamine
or etomidate combined with xylazine for intraperitoneal anesthesia in
four mouse strains. J Am Assoc Lab Anim Sci. (2020) 59:519–30.
doi: 10.30802/AALAS-JAALAS-19-000129
8. Arras M, Autenried P, Rettich A, Spaeni D, Rülicke T. Optimization of
intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects,
and anesthesia depth. Comp Med. (2001) 51:443–56.

1. Department of Agriculture US. Annual Report Animal Usage by Fiscal
Year. (2017).
2. Taylor K, Alvarez LR. An estimate of the number of animals used for
scientific purposes worldwide in 2015. Altern Lab Anim. (2019) 47:196–213.
doi: 10.1177/0261192919899853
3. Taylor K, Gordon N, Langley G, Higgins W. Estimates for worldwide
laboratory animal use in 2005. Altern Lab Anim. (2008) 36:327–42.
doi: 10.1177/026119290803600310
4. Buitrago S, Martin TE, Tetens-Woodring J, Belicha-Villanueva A, Wilding GE.
Safety and efficacy of various combinations of injectable anesthetics in BALB/c
mice. J Am Assoc Lab Anim Sci. (2008) 47:11–7.

Frontiers in Veterinary Science | www.frontiersin.org

6

July 2021 | Volume 8 | Article 651202

Jara et al.

A Mobile App for Anesthetic Calculation

9. Green CJ, Knight J, Precious S, Simpkin S. Ketamine alone and combined with
diazepam or xylazine in laboratory animals: a 10 year experience. Lab Anim.
(1981) 15:163–70. doi: 10.1258/002367781780959107
10. Levin-Arama M, Abraham L, Waner T, Harmelin A, Steinberg DM, Lahav
T, et al. Subcutaneous compared with intraperitoneal ketamine xylazine for
anesthesia of mice. J Am Assoc Lab Anim Sci. (2016) 55:794–800.
11. Jaber SM, Hankenson FC, Heng K, McKinstry-Wu A, Kelz MB, Marx JO. Dose
regimens, variability, and complications associated with using repeat-bolus
dosing to extend a surgical plane of anesthesia in laboratory mice. J Am Assoc
Lab Anim Sci. (2014) 53:684–91.
12. Whitehead L, Seaton P. The Effectiveness of self-management mobile phone
and tablet apps in long-term condition management: a systematic review. J
Med Internet Res. (2016) 18:e97. doi: 10.2196/jmir.4883
13. Pierce JMT, Taylor R. Validation of the mathematics in the anaesthetic impact
calculator, a smartphone app for the calculation the CO2 e of inhalational
anaesthesia. Anaesthesia. (2020) 75:136–8. doi: 10.1111/anae.14896
14. National Research Council Committee for the Update of the Guide for the
Care and Use of Laboratory Animals. The National Academies Collection:
Reports funded by National Institutes of Health. Guide for the Care and Use
of Laboratory Animals. Washington, DC: National Academies Press. (2011).
Copyright © National Academy of Sciences.
15. Wang X, Ge J, Tredget EE, Wu Y. The mouse excisional wound splinting
model, including applications for stem cell transplantation. Nat Protoc. (2013)
8:302–9. doi: 10.1038/nprot.2013.002
16. Cetin A, Komai S, Eliava M, Seeburg PH, Osten P. Stereotaxic gene delivery in
the rodent brain. Nat Protoc. (2006) 1:3166–73. doi: 10.1038/nprot.2006.450
17. Zou G, A modified Poisson regression approach to prospective studies with
binary data. Am J Epidemiol. (2004) 159:702–6. doi: 10.1093/aje/kwh090
18. Eger EI II. Isoflurane: a review Anesthesiology. (1981) 55:559–76.
doi: 10.1097/00000542-198111000-00014
19. Furukawa S, MacLennan MJ, Keller BB. Hemodynamic response to anesthesia
in pregnant and nonpregnant ICR mice. Lab Anim Sci. (1998) 48:357–63.
20. Steffey EP, Brosnan RJ, Galuppo LD, Mama KR, Imai A, Maxwell LK, et al.
Use of propofol-xylazine and the Anderson Sling Suspension System for
recovery of horses from desflurane anesthesia. Vet Surg. (2009) 38:927–33.
doi: 10.1111/j.1532-950X.2009.00599.x
21. Bringewatt T, Hopster K, Kästner SB, Rohn K, Ohnesorge B. Influence of
modified open lung concept ventilation on the cardiovascular and pulmonary

Frontiers in Veterinary Science | www.frontiersin.org

22.

23.

24.

25.
26.

27.
28.

function of horses during total intravenous anaesthesia. Vet Rec. (2010)
167:1002–6. doi: 10.1136/vr.c4172
Crumley MN, McMurphy RM, Hodgson DS, Kreider SE. Effects of
inspired oxygen concentration on ventilation, ventilatory rhythm, and gas
exchange in isoflurane-anesthetized horses. Am J Vet Res. (2013) 74:183–90.
doi: 10.2460/ajvr.74.2.183
Benmansour P, Duke-Novakovski T. Prolonged anesthesia using sevoflurane,
remifentanil and dexmedetomidine in a horse. Vet Anaesth Analg. (2013)
40:521–6. doi: 10.1111/vaa.12048
Schier MF, Raisis AL, Secombe CJ, Hosgood G, Musk GC, Lester
GD. Effects of dobutamine hydrochloride on cardiovascular function in
horses anesthetized with isoflurane with or without acepromazine maleate
premedication. Am J Vet Res. (2016) 77:1318–24. doi: 10.2460/ajvr.77.
12.1318
Edwards S, Axe S. The 10 ‘R’s of safe multidisciplinary drug administration.
Nurse Prescribing. (2015) 13:398–406. doi: 10.12968/npre.2015.13.8.398
Wagner A, Gray J, Corley J, Wolber D. Using app inventor in a K-12 summer
camp. In: Proceeding of the 44th ACM Technical Symposium on Computer
Science Education. Denver, CO: Association for Computing Machinery (2013).
p. 621–6. doi: 10.1145/2445196.2445377
Harinath R, ed. GSM Based Home Automation System Using App-Inventor for
Android Mobile Phone (2015).
Anderson K, Burford O, Emmerton L. Mobile health apps to facilitate selfcare: a qualitative study of user experiences. PLoS ONE. (2016) 11:e0156164.
doi: 10.1371/journal.pone.0156164

Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 Jara, Carraro, Zanesco, Andrade, Moreira, Nogueira, Souza,
Prado, Póvoa, Velander, Velloso and Araújo. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.

7

July 2021 | Volume 8 | Article 651202

